IQVIA Holdings, Inc. (IQV)
264.03
-7.01
(-2.59%)
USD |
NYSE |
Oct 16, 15:01
IQVIA Holdings SG&A Expense (TTM) : 2.058B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.058B |
| March 31, 2026 | 1.993B |
| December 31, 2025 | 1.999B |
| September 30, 2025 | 1.984B |
| June 30, 2025 | 1.992B |
| March 31, 2025 | 1.992B |
| December 31, 2024 | 1.992B |
| September 30, 2024 | 2.095B |
| June 30, 2024 | 2.075B |
| March 31, 2024 | 2.048B |
| December 31, 2023 | 2.053B |
| September 30, 2023 | 2.08B |
| June 30, 2023 | 2.095B |
| March 31, 2023 | 2.096B |
| December 31, 2022 | 2.071B |
| September 30, 2022 | 2.03B |
| June 30, 2022 | 2.011B |
| March 31, 2022 | 2.01B |
| December 31, 2021 | 1.964B |
| September 30, 2021 | 1.913B |
| June 30, 2021 | 1.875B |
| March 31, 2021 | 1.824B |
| December 31, 2020 | 1.789B |
| September 30, 2020 | 1.782B |
| June 30, 2020 | 1.717B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.722B |
| December 31, 2019 | 1.734B |
| September 30, 2019 | 1.693B |
| June 30, 2019 | 1.727B |
| March 31, 2019 | 1.715B |
| December 31, 2018 | 1.716B |
| September 30, 2018 | 1.742B |
| June 30, 2018 | 1.707B |
| March 31, 2018 | 1.661B |
| December 31, 2017 | 1.622B |
| September 30, 2017 | 1.543B |
| June 30, 2017 | 1.383B |
| March 31, 2017 | 1.255B |
| December 31, 2016 | 1.100B |
| September 30, 2016 | 953.80M |
| June 30, 2016 | 951.56M |
| March 31, 2016 | 926.90M |
| December 31, 2015 | 920.98M |
| September 30, 2015 | 901.97M |
| June 30, 2015 | 889.59M |
| March 31, 2015 | 882.70M |
| December 31, 2014 | 882.34M |
| September 30, 2014 | 890.08M |
| June 30, 2014 | 870.63M |
| March 31, 2014 | 880.45M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Medpace Holdings, Inc. | 189.02M |
| Charles River Laboratories International, Inc. | 762.04M |
| Fortrea Holdings, Inc. | 412.40M |
| OmniAb, Inc. | 26.89M |
| Seer, Inc. (California) | 40.06M |